Quarterly report pursuant to Section 13 or 15(d)

3. Significant Strategic Collaborations (Details Narrative)

v3.20.2
3. Significant Strategic Collaborations (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenue $ 112,927 $ 0 $ 169,676 $ 0
Takeda [Member] | Royalty [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Revenue $ 113,000   $ 170,000